Klox Technologies Inc a Canada-based regenerative medicine company focused on the development and commercialisation of its proprietary fluorescent light energy biomodulation System (FB System) in dermatology, wound care, and animal health, announced yesterday that it has named Domenic Serafino and Dr Richard Markoff as its new directors.
Serafino is a medical device veteran, with more than 25 years of experience. Presently, he serves as chairman and CEO of Venus Concept with direct operations in 27 of these markets and over 500 employees. He brings extensive experience in sales, marketing and global operations.
Dr Markoff has more than 25 years' experience as a supply chain executive. He is co-founder and partner at Innovobot and earlier managed Global Supply Chain Standards at L'Oreal cosmetics. He holds a PhD in Supply Chain Management and is a lecturer and researcher at Ecole polytechnique federale de Lausanne and the International Institute for Management Development in Switzerland.
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign